A complete application in a minute — tailored resume and cover letter, ready to send.
Johnson & Johnson Health Care Systems Inc. seeks a Director, Market Access Marketing, Precision Medicine & Solid Tumor Pipeline to advance U.S.
precision medicine market access capabilities and to lead strategy and launch readiness for late-stage Solid Tumor Prostate assets. The role partners with PS&E Precision Medicine, NPBD, Global MA, and inline Value, Access & Pricing teams to ensure access, evidence, testing, and payer perspectives are embedded in development and commercialization plans
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Market Access
Health Economics Market Access
People Leader
Horsham, Pennsylvania, United States of America, Titusville, New Jersey, United States of America
Johnson & Johnson Health Care Systems Inc. (Strategic Customer Group, SCG) is recruiting for a Director, Market Access Marketing, Precision Medicine & Solid Tumor Pipeline.
This role has dual accountability for advancing U.S. Precision Medicine Market Access capabilities and leading Market Access strategy and launch readiness for late-stage Solid Tumor Prostate pipeline assets.
The Director will serve as the primary Market Access partner to the Precision Medicine team within PS&E, embedding Precision Medicine access insights and capabilities across brand-aligned Market Access teams while shaping access, evidence, reimbursement, testing, and customer requirements for pipeline assets with Precision Medicine components.
In parallel, the Director will lead Market Access planning and execution for late-stage Prostate pipeline assets, serving as a critical bridge between New Product Business Development (NPBD), Precision Medicine, Global Market Access, and inline Value, Access & Pricing teams.
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
Serve as the primary Market Access partner to the PS&E Precision Medicine team.
Embed Precision Medicine Market Access capabilities, insights, tools, and best practices across brand-aligned Market Access teams.
Lead the development and evolution of Precision Medicine Market Access customer-facing resources and engagement strategies that enable PMAMs to effectively address biomarker testing access, coverage, reimbursement, and patient identification barriers, including support for the launch of an asset and future precision medicine-enabled assets.
Translate evolving payer, provider, laboratory benefit manager, and testing-market dynamics into actionable strategies that improve testing access, patient identification, and treatment adoption.
Partner across Global Market Access, NPBD, Medical Affairs, Value & Evidence, Commercial, and Brand teams to shape Market Access requirements for pipeline assets with Precision Medicine components.
Ensure access, evidence, testing, and customer perspectives are incorporated into development and commercialization plans to support successful future launches.
Lead Market Access strategy, go-to-market planning, and launch readiness for late-stage Solid Tumor Prostate pipeline assets.
Serve as the primary bridge between NPBD and inline VAP teams to ensure seamless transition from development through launch.
Represent Market Access strategy within launch readiness and commercialization governance forums.
Anticipate and address evolving payer, provider, pathway, reimbursement, and biomarker-testing dynamics to optimize launch success.
Manage key agency partnerships and budgets to deliver high-quality execution.